Funding round led by Advent Life Sciences. New investors include Emerson Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala and the Minderoo Foundation. Proceeds […]
…to Fill Industry Gap in Process Analytical Technologies for Downstream Processing Merck today announced that it has entered a collaboration with Agilent Technologies to advance […]
Your Excellency President Macron,Excellency President Macky Sall,Excellency President Abdel Fattah Al-Sisi,Excellency President Kenyatta,Excellency President Buhari,Excellency President Saied,Excellency President Michel,Excellency President von der Leyen,Excellencies, dear colleagues, […]
Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the […]
….of the Life Science business sector. • New operating model to accelerate profitable growth strategy • Newly formed Life Science Services business unit to offer […]
Sellig Will Drive Enhanced Customer Service and Go-To-Market Strategy Adare Pharma Solutions (“Adare”), a global, technology-driven contract development and manufacturing organization (CDMO), today announced the […]
Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]
Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects […]
Hygiene and health company Essity has acquired the orthopedic specialist company AquaCast Liner, a provider of waterproof cast liners on the US market. Growing through […]
.. adds the premiere digital-first agency network to the market leader in next generation commercialization EVERSANA™, the pioneer of next generation commercial services to the […]
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and […]
COVID-19 pandemic disrupts health services worldwide New evidence compiled by the World Health Organization and the World Bank shows that the COVID-19 pandemic is likely […]
Updated 48-week data from Phase III ASCEMBL trial consistent with improved major molecular response (MMR) rate of Scemblix® (asciminib) vs. Bosulif®* (bosutinib) and lower discontinuation […]
Merck today announced the expansion of its strategic, corporate venture capital arm M Ventures. Merck, a leading science and technology company, today announced the expansion […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it completed the repurchase of Roche shares that had been held by Novartis. On 4 November […]
Copyright © 2022 | WordPress Theme by MH Themes
